Published in J Clin Endocrinol Metab on September 01, 1998
Lipoprotein(a) metabolism: potential sites for therapeutic targets. Metabolism (2012) 1.08
Dietary monounsaturated fat activates metabolic pathways for triglyceride-rich lipoproteins that involve apolipoproteins E and C-III. Am J Clin Nutr (2008) 1.03
Studying apolipoprotein turnover with stable isotope tracers: correct analysis is by modeling enrichments. J Lipid Res (2006) 0.92
Structure, function, and genetics of lipoprotein (a). J Lipid Res (2016) 0.83
Lipoprotein(a): biology and clinical importance. Clin Biochem Rev (2004) 0.83
Healthy dietary interventions and lipoprotein (a) plasma levels: results from the Omni Heart Trial. PLoS One (2014) 0.78
Distinct metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein(a). Metabolism (2015) 0.77
A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med (1997) 19.93
A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med (1991) 6.13
Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr (1999) 5.12
A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA (1996) 3.69
Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial. Ann Intern Med (2001) 3.56
Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators. Circulation (1999) 3.26
Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation (1998) 3.19
Effects on blood lipids of a blood pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH) Trial. Am J Clin Nutr (2001) 3.12
Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. Circulation (2005) 2.77
Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med (1991) 2.68
Prospective study of plasma fatty acids and risk of prostate cancer. J Natl Cancer Inst (1994) 2.68
Comparison of measures of fatty acid intake by subcutaneous fat aspirate, food frequency questionnaire, and diet records in a free-living population of US men. Am J Epidemiol (1992) 2.68
A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease. Proc Natl Acad Sci U S A (2006) 2.41
Comparison of the effects of oat bran and low-fiber wheat on serum lipoprotein levels and blood pressure. N Engl J Med (1990) 2.37
Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res (1999) 2.30
Randomised trial of fish oil for prevention of restenosis after coronary angioplasty. Lancet (1989) 2.28
The relation between dietary intake and adipose tissue composition of selected fatty acids in US women. Am J Clin Nutr (1998) 2.24
Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial. Ann Intern Med (1998) 2.22
Fatty acid composition of the subcutaneous adipose tissue and risk of proliferative benign breast disease and breast cancer. J Natl Cancer Inst (1993) 2.15
Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group. Ann Intern Med (1996) 2.03
Effect of estrogen on very low density lipoprotein and low density lipoprotein subclass metabolism in postmenopausal women. J Clin Endocrinol Metab (1997) 1.88
Cardiovascular disease in women. Circulation (1993) 1.87
Application of the method of triads to evaluate the performance of food frequency questionnaires and biomarkers as indicators of long-term dietary intake. Am J Epidemiol (2001) 1.85
Fatty acid composition of subcutaneous adipose tissue and diet in postmenopausal US women. Am J Clin Nutr (1991) 1.78
Low-density lipoprotein size, pravastatin treatment, and coronary events. JAMA (2001) 1.75
A prospective study of egg consumption and risk of cardiovascular disease in men and women. JAMA (1999) 1.74
Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trial. J Am Coll Cardiol (1998) 1.67
Thermal balloon and rollerball ablation to treat menorrhagia: a multicenter comparison. Obstet Gynecol (1998) 1.61
Plasma lipids and lipoproteins in vegetarians and controls. N Engl J Med (1975) 1.59
Effect of transport conditions on the stability of biochemical markers in blood. Clin Chem (1989) 1.58
Chewing the fat--how much and what kind? N Engl J Med (1991) 1.57
Beta-carotene supplementation for patients with low baseline levels and decreased risks of total and prostate carcinoma. Cancer (1999) 1.50
Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med (1994) 1.48
The DASH Diet, Sodium Intake and Blood Pressure Trial (DASH-sodium): rationale and design. DASH-Sodium Collaborative Research Group. J Am Diet Assoc (1999) 1.40
Blood pressure in vegetarians. Am J Epidemiol (1974) 1.40
Fine needle aspiration of retroperitoneal human dirofilariasis with a pseudotumoral presentation. Acta Cytol (1990) 1.40
Is there anything to add to our lipid risk factors for coronary heart disease? Am J Cardiol (1995) 1.39
The effect of dietary patterns on blood pressure control in hypertensive patients: results from the Dietary Approaches to Stop Hypertension (DASH) trial. Am J Hypertens (2000) 1.39
Dietary fiber and cardiovascular disease--direct protection or indicator of a healthy lifestyle? Am J Prev Med (1993) 1.38
Relation of vessel wall shear stress to atherosclerosis progression in human coronary arteries. Arterioscler Thromb (1993) 1.38
Consumption of trans fats and estimated effects on coronary heart disease in Iran. Eur J Clin Nutr (2007) 1.38
Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution. Results from the Framingham Offspring Study. Arteriosclerosis (1987) 1.26
Effect of dietary patterns on ambulatory blood pressure : results from the Dietary Approaches to Stop Hypertension (DASH) Trial. DASH Collaborative Research Group. Hypertension (1999) 1.14
Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women. Circulation (1998) 1.13
Ingestion of egg raises plasma low density lipoproteins in free-living subjects. Lancet (1984) 1.12
Dietary Approaches to Stop Hypertension: rationale, design, and methods. DASH Collaborative Research Group. J Am Diet Assoc (1999) 1.11
Distinct patterns of lipoproteins with apoB defined by presence of apoE or apoC-III in hypercholesterolemia and hypertriglyceridemia. J Lipid Res (2001) 1.11
Estradiol with or without progesterone and ambulatory blood pressure in postmenopausal women. Hypertension (1999) 1.09
A prospective study of nutritional factors and hypertension among US women. Circulation (1989) 1.08
Individual saturated fatty acids and nonfatal acute myocardial infarction in Costa Rica. Eur J Clin Nutr (2003) 1.06
Dietary patterns and risk of nonfatal acute myocardial infarction in Costa Rican adults. Eur J Clin Nutr (2006) 1.05
The association of dietary fat with serum cholesterol in vegetarians: the effect of dietary assessment on the correlation coefficient. Am J Epidemiol (1988) 1.03
Summary of the scientific conference on dietary fatty acids and cardiovascular health: conference summary from the nutrition committee of the American Heart Association. Circulation (2001) 1.02
Patterns of tumor initiation in choroidal melanoma. Cancer Res (2000) 1.02
Change in dietary saturated fat intake is correlated with change in mass of large low-density-lipoprotein particles in men. Am J Clin Nutr (1998) 1.01
Angiotensinogen genotype and blood pressure response in the Dietary Approaches to Stop Hypertension (DASH) study. J Hypertens (2001) 1.00
Relation of moderate alcohol consumption and risk of systemic hypertension in women. Am J Cardiol (1990) 0.99
Validation of a food frequency questionnaire measurement of selected nutrients using biological markers in African-American men. Eur J Clin Nutr (2007) 0.99
Impact and evolution of peliosis hepatis in renal transplant recipients. Transplantation (1994) 0.98
Addition of alendronate to ongoing hormone replacement therapy in the treatment of osteoporosis: a randomized, controlled clinical trial. J Clin Endocrinol Metab (1999) 0.98
Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases. Arthritis Rheum (2000) 0.98
Implications of the ACCORD lipid study: perspective from the Residual Risk Reduction Initiative (R(3)i). Curr Med Res Opin (2010) 0.97
Effects of postmenopausal hormone replacement with oral and transdermal estrogen on high density lipoprotein metabolism. J Lipid Res (1994) 0.97
Coagulation activation following estrogen administration to postmenopausal women. Thromb Haemost (1992) 0.96
Cost-effectiveness of pravastatin therapy for survivors of myocardial infarction with average cholesterol levels. Am Heart J (2001) 0.96
Effects of estrogenic oral contraceptives on the lipoprotein B particle system defined by apolipoproteins E and C-III content. J Lipid Res (1999) 0.96
Prophylactic use of OKT3 monoclonal antibody in cadaver kidney recipients. Utilization of OKT3 as the sole immunosuppressive agent. Transplantation (1986) 0.96
Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations. Cholesterol and Recurrent Events CARE Investigators. J Am Coll Cardiol (1999) 0.96
Population-based study of alpha- and gamma-tocopherol in plasma and adipose tissue as biomarkers of intake in Costa Rican adults. Am J Clin Nutr (2001) 0.96
Lipid-lowering therapy in acute coronary syndromes. JAMA (2001) 0.94
Genetic polymorphism of CYP1A2 increases the risk of myocardial infarction. J Med Genet (2004) 0.94
A 12-month comparative study of raloxifene, estrogen, and placebo on the postmenopausal endometrium. Obstet Gynecol (2000) 0.93
Usefulness of plasma phospholipid N-3 fatty acid levels in predicting dietary fish intake in patients with coronary artery disease. Am J Cardiol (1990) 0.92
Tobacco smoking modifies association between Gln-Arg192 polymorphism of human paraoxonase gene and risk of myocardial infarction. Arterioscler Thromb Vasc Biol (2000) 0.92
A prospective study of plasma fish oil levels and incidence of myocardial infarction in U.S. male physicians. J Am Coll Cardiol (1995) 0.91
The effect of potassium supplementation in persons with a high-normal blood pressure. Results from phase I of the Trials of Hypertension Prevention (TOHP). Trials of Hypertension Prevention (TOHP) Collaborative Research Group. Ann Epidemiol (1995) 0.90
Sex hormones and lipoprotein metabolism. Curr Opin Lipidol (1994) 0.90
More on chewing the fat. The good fat and the good cholesterol. N Engl J Med (1991) 0.90
Quantitative angiographic and statistical methods to assess serial changes in coronary luminal diameter and implications for atherosclerosis regression trials. Am J Cardiol (1992) 0.89
Effect of ingestion of meat on plasma cholesterol of vegetarians. JAMA (1981) 0.89
Differential metabolism of human VLDL according to content of ApoE and ApoC-III. Arterioscler Thromb Vasc Biol (2001) 0.89
Biomarkers of dairy intake and the risk of heart disease. Nutr Metab Cardiovasc Dis (2011) 0.89
Cholesterol and Recurrent Events: a secondary prevention trial for normolipidemic patients. CARE Investigators. Am J Cardiol (1995) 0.89
Effect of linoleic and oleic acids on blood pressure, blood viscosity, and erythrocyte cation transport. J Am Coll Nutr (1987) 0.88
Fatty Acid desaturase gene variants, cardiovascular risk factors, and myocardial infarction in the costa rica study. Front Genet (2012) 0.88
Effects of a low-fat diet on plasma lipoprotein levels. Arch Intern Med (1986) 0.88
The platelet Pl(A2) and angiotensin-converting enzyme (ACE) D allele polymorphisms and the risk of recurrent events after acute myocardial infarction. Am J Cardiol (2001) 0.87
Lack of an effect of dietary saturated fat and cholesterol on blood pressure in normotensives. Hypertension (1984) 0.87
Patterns of contagion in self-mutilation epidemics. Am J Psychiatry (1989) 0.87
Effects of low dose oral contraceptives on very low density and low density lipoprotein metabolism. J Clin Invest (1993) 0.86
Plasma lipoprotein levels in vegetarians. The effect of ingestion of fats from dairy products. JAMA (1985) 0.86
Comparison of alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal women. J Clin Endocrinol Metab (2000) 0.86